"James has secured the Chinese deal surprising everyone for around 8-9% of global population and a deal worth hundreds of millions - then again the Cantrixil deal when some here predicted it was worthless - 40 million dollar milestone payment structure and around 12% royalty was achieved…'
-------------
Enough of this nonsense rikki - your views and opinions expressed here, are exactly the problem with this underperforming CEO.
I know exactly what has been happening with Cantrixil, over with Vesesto. - DO YOU ? basically given away, by the company.
I cringe at what is happening with a less potent version of Cantrixil - in clinical trials under NOX. Awful that for peanuts this great drug did not stay in Australia. Why ? Anything to do with management at NOX. ....and why this disappointment of a company KAZIA (so far) - did not consider broader issues.
- Forums
- ASX - By Stock
- Ann: Trading Halt
"James has secured the Chinese deal surprising everyone for...
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)